Curcumin - a viable agent for better bladder cancer treatment

  • Although the therapeutic armamentarium for bladder cancer has considerably widened in the last few years, severe side effects and the development of resistance hamper long-term treatment success. Thus, patients turn to natural plant products as alternative or complementary therapeutic options. One of these is curcumin, the principal component of Curcuma longa that has shown chemopreventive effects in experimental cancer models. Clinical and preclinical studies point to its role as a chemosensitizer, and it has been shown to protect organs from toxicity induced by chemotherapy. These properties indicate that curcumin could hold promise as a candidate for additive cancer treatment. This review evaluates the relevance of curcumin as an integral part of therapy for bladder cancer.

Download full text files

Export metadata

Author:Jochen RutzGND, Andrea JanicováGND, Katja Woidacki, Felix ChunORCiDGND, Roman A. BlahetaORCiD, Borna ReljaORCiDGND
Parent Title (English):International journal of molecular sciences
Place of publication:Basel
Document Type:Article
Date of Publication (online):2020/05/26
Date of first Publication:2020/05/26
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2020/08/14
Tag:bioavailability; bladder cancer; chemoprotection; chemoresistance; curcumin
Issue:11, art. 3761
Page Number:20
First Page:1
Last Page:20
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Licence (German):License LogoCreative Commons - Namensnennung 4.0